Evidence map›Paper›PMID 30389665›Full record

ArticleThe EMBO journal2018

Hepatic Sel1L-Hrd1 ER-associated degradation (ERAD) manages FGF21 levels and systemic metabolism via CREBH.

Asmita Bhattacharya, Shengyi Sun, Heting Wang, Ming Liu, Qiaoming Long, Lei Yin, Sander Kersten, Kezhong Zhang, Ling Qi

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. SEL1L-HRD1-mediated ERAD in mammals.Nature cell biology · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Asmita BhattacharyaDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID 0000-0002-5669-8036
Shengyi SunDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Heting WangDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China.
Ming LiuDivision of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Qiaoming LongCam-Su Mouse Genomic Resource Center, Soochow University, Suzhou, Jiangsu, China qmlong@suda.edu.cn lingq@med.umich.edu.ORCID 0000-0001-8243-589X
Lei YinDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA.
Sander KerstenNutrition Metabolism and Genomics Group, Wageningen University, Wageningen, The Netherlands.
Kezhong ZhangDepartment of Biochemistry, Microbiology, and Immunology, Center for Molecular Medicine and Genetics Wayne State University School of Medicine, Detroit, MI, USA.ORCID 0000-0002-6062-235X
Ling QiDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA qmlong@suda.edu.cn lingq@med.umich.edu.ORCID 0000-0001-8229-0184
University of Michigan · USCornell University · USSoochow University · CNThe University of Texas Southwestern Medical Center · USTianjin Medical University General Hospital · CNWayne State University · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OWYANG, CHUNG · 1986 to 2021
$22.5M
Structure, Composition, & Histology Core - Core BP30AR069620 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KARL J JEPSEN · 2016 to 2026
$8.4M
Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + SecretionR01DK111174 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ARVAN, PETER, QI, LING · 2016 to 2024
$5.5M
Regulation of Hepatic Steatosis by an ER Stress-Inducible Transcription Factor CRR01DK090313 · NIDDK · WAYNE STATE UNIVERSITY · PI Kezhong Zhang · 2011 to 2026
$5.0M
Novel Role of Hepatic SEL1L-HRD1 ERAD in FGF21 Gene TranscriptionR01DK120330 · NIDDK · UNIVERSITY OF VIRGINIA · PI Deyu Fang, Ling Qi · 2018 to 2026
$4.9M
Significance and mechanisms of hepatic ChREBPα induction via post-translational modifications in diet-induced NASHR01DK099593 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YIN, LEI · 2014 to 2025
$4.5M
Defining the Central Role of ER-Associated Degradation (ERAD) in Neuroendocrine CellsR01DK120047 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI QI, LING · 2018 to 2021
$1.6M
The Role of Sel1L and ER Quality Control in AdipocytesR01DK105393 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI QI, LING · 2015 to 2018
$1.4M
REGULATION OF IRE1A SIGNALING BY THE SEL1L-HRD1 ERAD COMPLEXR01GM113188 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI QI, LING · 2015 to 2018
$1.2M
Howard Hughes Medical InstituteNIAMS NIH HHS P30 AR069620NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK034933NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK090313NIDDK NIH HHS R01 DK099593NIDDK NIH HHS R01 DK105393NIDDK NIH HHS R01 DK111174NIDDK NIH HHS R01 DK120047NIDDK NIH HHS R01 DK120330NIGMS NIH HHS R01 GM113188
6 · The paper itself

Abstract

Fibroblast growth factor 21 (Fgf21) is a liver-derived, fasting-induced hormone with broad effects on growth, nutrient metabolism, and insulin sensitivity. Here, we report the discovery of a novel mechanism regulating

Indexed as

Endoplasmic Reticulum-Associated DegradationEnergy MetabolismAnimalsCyclic AMP Response Element-Binding ProteinFibroblast Growth FactorsIntracellular Signaling Peptides and ProteinsLiverMiceMice, Mutant StrainsPPAR alphaProteinsTranscription, GeneticUbiquitinationUbiquitin-Protein LigasesCreb3l3 protein, mouseCyclic AMP Response Element-Binding Proteinfibroblast growth factor 21Fibroblast Growth FactorsIntracellular Signaling Peptides and ProteinsPPAR alphaPpara protein, mouseProteinsSel1h protein, mouseSyvn1 protein, mouseUbiquitin-Protein LigasesER quality controlFGF21gene transcriptionmetabolismSel1L‐Hrd1 ERAD

Identifiers

PMID30389665
PMCPMC6236331
OpenAlexW2899448135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.